Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
mRNA-1273 Emergency use authorization Experimental Vaccine Jul/11/2022 28 1
Cepharanthine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 6 0
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Hemin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/13/2021 1 1
Narlaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/04/2021 3 0
Calpeptin Potential treatment - pre-clinical evidence Experimental Antiviral Feb/01/2021 1 0
Ciluprevir Potential treatment - pre-clinical evidence Experimental Antiviral Feb/01/2021 1 0
Ebselen Potential treatment - pre-clinical evidence Experimental Antiviral Feb/01/2021 3 2
PYR-41 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/01/2021 1 0
Aurothioglucose Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/01/2021 1 0
Excel (.xslx) CSV (.csv)